Novus Holdings Ltd
JSE:NVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novus Holdings Ltd
JSE:NVS
|
ZA |
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
US |
Intrinsic Value
The intrinsic value for Novus Holdings Ltd (NVS) under the Base Case is 605.59 Zac. Compared with the current market price of 550 Zac, the stock appears Undervalued by 9%.
DCF suggests overvaluation, while multiples suggest undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Novus Holdings Ltd.
The intrinsic value for Novus Holdings Ltd (NVS) under the Base Case is 605.59 Zac.
Compared with the current market price of 550 Zac, the stock appears Undervalued by 9%.